Company
Headquarters: Madrid, Spain
Employees: 1,025
CEO: Mr. Eduardo Baviera Sabater
€517.9 Million
EUR as of Jan. 1, 2025
US$538.9 Million
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $219.88 B |
Danaher | $177.43 B |
Siemens Healthineers AG | $59.19 B |
Agilent Technologies, Inc. | $43.57 B |
Lonza Group Ltd | $41.66 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.
Clínica Baviera, SA has the following listings and related stock indices.
Stock: FSX: D9Z wb_incandescent